Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Intarcia Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 10
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Intarcia Therapeutics Raises USD75 Million in Financing 13
Phoundry Pharma Raises USD0.5 Million in Seed Financing 14
Intarcia Therapeutics Raises US$200 Million In Venture Financing 15
Intarcia Therapeutics Raises US$210 Million In Venture Financing 17
Intarcia Therapeutics Raises Additional US$5.5 Million In Venture financing 19
Intarcia Therapeutics Raises US$7.3 Million In Venture financing 20
Intarcia Therapeutics Secures US$13.28 Million In Third Tranche Of Venture Financing Round 22
Partnerships 23
Intarcia Therapeutics Enters into Co-Development Agreement with Numab 23
Intarcia Therapeutics Enters into Co-Development Agreement with Servier for ITCA 650 24
Intarcia Therapeutics Enters Into Co-Development Agreement With Quintiles For ITCA 650 25
Licensing Agreements 27
Intarcia Therapeutics Enters into Licensing Agreement with California Institute for Biomedical Research 27
Intarcia Therapeutics Plans To License Drug-Formulation Technology 28
Equity Offering 29
Intarcia Therapeutics Raises USD206 Million in Second Tranche of Private Placement of Shares 29
Intarcia Therapeutics Raises USD215 Million in First Tranche of Private Placement of Shares 30
Debt Offering 31
Intarcia Therapeutics Raises USD300 Million in Financing 31
Acquisition 32
Intarcia Therapeutics Acquires Phoundry Pharma 32
Intarcia Therapeutics Inc – Key Competitors 33
Intarcia Therapeutics Inc – Key Employees 34
Intarcia Therapeutics Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Government and Public Interest 36
Jun 12, 2016: New NHANES Analysis Shows No Improvement in Last Decade to Get More Diabetes Patients to HbA1c Goal 36
Product News 38
09/15/2017: New Intarcia Study Evaluates Optimal Way to Switch from Daily Liraglutide Injections to ITCA 650 in Patients with Type 2 Diabetes 38
06/02/2016: Intarcia and Numab Announce Achievement of Key Research and Development Milestones 39
Product Approvals 40
Feb 03, 2017: Intarcia Announces FDA Filing Acceptance of New Drug Application (NDA) for ITCA 650 for the Treatment of Type 2 Diabetes 40
Nov 21, 2016: Intarcia Submits New Drug Application (NDA) to FDA for U.S. Marketing Approval of ITCA 650 in Type 2 Diabetes 41
Clinical Trials 42
Jun 12, 2016: Intarcia Presents FREEDOM-2 Trial Results in Type 2 Diabetes Demonstrating Clinically Meaningful Superiority and Sustained Glucose Control and Weight Reduction for ITCA 650 vs. Januvia: Oral Presentation at ADA 76th Scientific Sessions 42
May 06, 2016: Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Intarcia Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 9
Intarcia Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 10
Intarcia Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Intarcia Therapeutics Raises USD75 Million in Financing 13
Phoundry Pharma Raises USD0.5 Million in Seed Financing 14
Intarcia Therapeutics Raises US$200 Million In Venture Financing 15
Intarcia Therapeutics Raises US$210 Million In Venture Financing 17
Intarcia Therapeutics Raises Additional US$5.5 Million In Venture financing 19
Intarcia Therapeutics Raises US$7.3 Million In Venture financing 20
Intarcia Therapeutics Secures US$13.28 Million In Third Tranche Of Venture Financing Round 22
Intarcia Therapeutics Enters into Co-Development Agreement with Numab 23
Intarcia Therapeutics Enters into Co-Development Agreement with Servier for ITCA 650 24
Intarcia Therapeutics Enters Into Co-Development Agreement With Quintiles For ITCA 650 25
Intarcia Therapeutics Enters into Licensing Agreement with California Institute for Biomedical Research 27
Intarcia Therapeutics Plans To License Drug-Formulation Technology 28
Intarcia Therapeutics Raises USD206 Million in Second Tranche of Private Placement of Shares 29
Intarcia Therapeutics Raises USD215 Million in First Tranche of Private Placement of Shares 30
Intarcia Therapeutics Raises USD300 Million in Financing 31
Intarcia Therapeutics Acquires Phoundry Pharma 32
Intarcia Therapeutics Inc, Key Competitors 33
Intarcia Therapeutics Inc, Key Employees 34
Intarcia Therapeutics Inc, Other Locations 35
Intarcia Therapeutics Inc, Subsidiaries 35